Allopurinol for the treatment of chronic kidney disease: asystematic review
Open Access
- 1 June 2014
- journal article
- research article
- Published by National Institute for Health and Care Research in Health Technology Assessment
- Vol. 18 (40) , 1-78
Abstract
Health Technology Assessment Volume: 18, Issue: 40, Published in June 2014Keywords
Funding Information
- National Institute for Health Research
This publication has 77 references indexed in Scilit:
- Starting dose is a risk factor for allopurinol hypersensitivity syndrome: A proposed safe starting dose of allopurinolArthritis & Rheumatism, 2012
- Prevalence of gout and hyperuricemia in the US general population: The National Health and Nutrition Examination Survey 2007-2008Arthritis & Rheumatism, 2011
- Using allopurinol above the dose based on creatinine clearance is effective and safe in patients with chronic gout, including those with renal impairmentArthritis & Rheumatism, 2011
- Drug Reaction With Eosinophilia and Systemic SymptomsArchives of Dermatology, 2010
- Risk Factors for End-Stage Renal DiseaseArchives of internal medicine (1960), 2009
- Effect of treatment of hyperuricemia with allopurinol on blood pressure, creatinine clearence, and proteinuria in patients with normal renal functionsInternational Urology and Nephrology, 2007
- Systematic Reviews in Health Care2001
- Non-responsiveness to allopurinol in renal hypouricaemiaJournal of Molecular Medicine, 1989
- The allopurinol hypersensitivity syndrome. Unnecessary morbidity and mortalityArthritis & Rheumatism, 1986
- Toxic Epidermal Necrolysis, Azotemia, and Death After Allopurinol TherapyJAMA, 1970